STOCK TITAN

BCB Bancorp (BCBP) 424B Filings

BCBP NASDAQ

Here are the 424B prospectus supplements from BCB Bancorp Inc (BCBP) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 424B covers the supplement that carries the terms of a priced offering, so if you follow BCBP and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full BCBP filings page.

Rhea-AI Summary

BCB Bancorp, Inc. (BCBP) is offering 11,000,000 shares of common stock at $7.75 per share under its shelf registration, for gross proceeds of $85.25 million (net proceeds of about $80.6 million before expenses), with a 30‑day underwriter option for up to 1,650,000 additional shares. Shares outstanding are expected to be 29,101,822 after the offering.

The company plans to use proceeds for general corporate purposes, including liquidity, working capital, supporting bank capital in connection with expected problem loan dispositions, reducing debt, and maintaining capital and liquidity ratios. Management projects for the quarter ending September 30, 2026 a substantial net loss of $126.2–$136.1 million, driven by an expected $112–$120 million provision for credit losses tied to the anticipated sale or transfer of about $306 million in problem and other loans and a $50 million valuation allowance against net deferred tax assets.

Pro forma for the offering and contemplated loan sales, total assets are projected at about $3.0 billion, with a bank Tier 1 leverage ratio of 9.0% and holding‑company Tier 1 leverage ratio of 8.1%, and tangible book value per share of $7.51.

Rhea-AI Summary

BCB Bancorp, Inc. (BCBP) plans a primary offering of common stock under its $100 million shelf registration, targeting approximately $75 million of gross proceeds in the third quarter of 2026 to support liquidity, regulatory capital and planned problem-loan dispositions.

The company is pursuing sizable credit de-risking actions, including marketing approximately $210 million of criticized and classified problem loans and an additional $96 million of commercial real estate and cannabis-related loans for sale or transfer to held for sale. These steps are expected to drive a very large third-quarter provision for credit losses in the range of $112–$120 million, a full valuation allowance of about $50 million against net deferred tax assets, and a projected net loss of $126.2–$136.1 million.

On a pro forma basis for the quarter ending September 30, 2026, total assets are projected at about $3.0 billion, with total gross loans of roughly $2.3 billion, deposits near $2.6 billion, and a Tier 1 leverage ratio of 7.9% at the holding company and 8.7% at the bank. Tangible book value per share is projected to decline from $14.73 at June 30, 2026 to $7.75 after the contemplated transactions, and dividends on common and preferred stock remain suspended following cumulative losses.